These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32141556)

  • 1. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
    Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
    Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
    Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of LncRNA AFAP1-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells through inhibiting wnt signaling pathway.
    Sun Y; Fan L; Li Y
    Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):176-180. PubMed ID: 38063100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1.
    Zha LF; Zhang LD; Pan HM; Ma HD
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1351-1357. PubMed ID: 33629305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lncRNA SNHG20 on proliferation and apoptosis of non-small cell lung cancer cells through Wnt/β-catenin signaling pathway.
    Wang ZX; Zhao Y; Yu Y; Liu N; Zou QX; Liang FH; Cheng KP; Lin FW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):230-237. PubMed ID: 31957836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncDBH-AS1 knockdown enhances proliferation of non-small cell lung cancer cells by activating the Wnt signaling pathway via the miR-155/AXIN1 axis.
    Shi XY; Tao XF; Wang GW; He JF; Wu LF; Sun YZ; Sun XJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):139-144. PubMed ID: 33506901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
    Rong L; Zhao R; Lu J
    Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
    Zhou C; An N; Cao C; Wang G
    J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
    Qiu Z; Pan XX; You DY
    Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
    Liu XB; Han C; Sun CZ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of LncRNA FAM83H-AS1 in hepatocellular carcinoma promotes cell proliferation, migration and invasion by Wnt/β-catenin pathway.
    Ma YK; Shen TH; Yang XY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7855-7862. PubMed ID: 31599410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Guo L; Fang L; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.
    Xu X; Zhang Y; Wang M; Zhang X; Jiang W; Wu S; Ti X
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):43-53. PubMed ID: 36017915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p/FOXK1 and thereby activating the Wnt/β-catenin signaling pathway.
    Zhang C; Huang J; Lou K; Ouyang H
    Cancer Med; 2022 Apr; 11(7):1589-1604. PubMed ID: 35166053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.